FDA approves Gilead's next-generation HIV prevention pill

FDA approves Gilead's next-generation HIV prevention pill

- in Health
52

Gilead Sciences, the drug giant behind the blockbuster HIV prevention pill Truvada, won FDA approval on Thursday to market Descovy — a medication already used by those who have HIV — as its next-generation prevention drug.

The final approval follows an August vote in favor of Descovy as a pre-exposure prophylaxis medication, or PrEP, by an FDA advisory panel.

Source

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like

Missing Milwaukee woman, two daughters found dead in garage

A missing Milwaukee woman and her two daughters